We utilize genomic, cistromic, transcriptomic, and proteomic data to dissect the various functions of steroid receptors and their coregulators. In particular, we are interested in identifying epigenetic signatures that can be applied as biomarkers to predict disease aggressiveness and response to treatment. We are particularly focused on identifying novel gene targets that can be exploited therapeutically for the treatment of prostate cancer.

Our current ongoing projects include: